This paper by James Gubb and Oliver Meller-Herbert, of the Civitas health Unit, revisits the anticipated benefits of the use of market mechanisms; asks on what theory they rest; and where the NHS currently stands.

Friday 29th January 2010 deadline

Microbial Solutions launches new Bioreactors for toxic waste disposal in Engineering Firms

The National Institute for Health and Clinical Excellence is launching a new programme focusing specifically on the evaluation of innovative medical technologies (including devices and diagnostics).